Skip to content
GLP-1 Scorecard
Menu
Graded #101

Layla

Layla is a US telehealth weight-loss program built around semaglutide, offering compounded semaglutide as injections and as oral dropper drops, plus compounded tirzepatide and a brand-inclusive GLP-1…

Visit LaylaWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$237/mo (all doses, compounded)
Tirzepatide
$199/mo (all doses, compounded)
Coverage
Coverage not published
Brand-name
Yes

Weigh Layla against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value66/100
Dose & formulation96/100
Clinical oversight76/100
Labs & monitoring52/100
Fulfillment65/100
Contract terms55/100

Strengths

  • Oral semaglutide dropper option plus injectable semaglutide and tirzepatide, with a brand-name upgrade path
  • Named Medical Director (Dr. Ruth Cohen) and 24-7 doctor messaging
  • Quiz-based intake with fast three to five day shipping

Where it loses points

  • Brand-inclusive GLP-1 program is expensive, starting around 1,299 dollars
  • States served are not published on the site
  • Support phone line uses a UK format, and the compounding pharmacy is not named

Bottom line — Grade C

Best for: People wanting oral or injectable semaglutide with a brand-inclusive glp-1 upgrade path.

Ranked #101 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest Layla — the realistic shortlist.

The 21 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect Layla's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Layla's site. Not medical advice; see our disclosure.

← Back to the scorecard